Ownership history in BARCLAYS PLC · 26 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 487,230 | -46,186 | -8.7% | 0.01% | $23.1M | — |
| 2025 Q2 | ADDED | 533,416 | +410,253 | +333.1% | 0.01% | $28.5M | — |
| 2025 Q1 | REDUCED | 123,163 | -9,674 | -7.3% | 0.00% | $5.0M | — |
| 2024 Q4 | ADDED | 132,837 | +5,169 | +4.0% | 0.00% | $3.7M | — |
| 2024 Q3 | ADDED | 127,668 | +71,652 | +127.9% | 0.00% | $3.7M | — |
| 2024 Q2 | REDUCED | 56,016 | -14,665 | -20.7% | 0.00% | $1.3M | — |
| 2024 Q1 | REDUCED | 70,681 | -175,593 | -71.3% | 0.00% | $1.8M | — |
| 2023 Q4 | ADDED | 246,274 | +114,828 | +87.4% | 0.00% | $5.8M | — |
| 2023 Q3 | REDUCED | 131,446 | -76,954 | -36.9% | 0.00% | $6.6M | — |
| 2023 Q3 | ADDED | 208,400 | +65,322 | +45.7% | 0.01% | $10.5M | — |